05:55 PM EDT, 05/28/2024 (MT Newswires) -- Compass Therapeutics ( CMPX ) said Tuesday its board of directors appointed Dr. Thomas Schuetz as chief executive officer, effective immediately.

Schuetz succeeds Dr. Vered Bisker-Leib, who is also stepping down from the board, Compass Therapeutics ( CMPX ) said.

The company said Bisker-Leib will be available as a senior consultant for the next 15 months.

Schuetz previously was president of research and development and vice chair of the board.